(NASDAQ: NSPR) Inspiremd's forecast annual revenue growth rate of 69.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Inspiremd's revenue in 2024 is $6,205,000.On average, 1 Wall Street analysts forecast NSPR's revenue for 2024 to be $166,307,223, with the lowest NSPR revenue forecast at $166,307,223, and the highest NSPR revenue forecast at $166,307,223. On average, 1 Wall Street analysts forecast NSPR's revenue for 2025 to be $343,639,044, with the lowest NSPR revenue forecast at $343,639,044, and the highest NSPR revenue forecast at $343,639,044.
In 2026, NSPR is forecast to generate $739,820,849 in revenue, with the lowest revenue forecast at $739,820,849 and the highest revenue forecast at $739,820,849.